The FDA has approved AstraZeneca's Fasenra for eosinophilic granulomatosis with polyangiitis based on Phase 3 MANDARA trial ...

Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...

Analysis of ctDNA in the MARIPOSA trial showed fewer EGFR alterations and MET amplifications after Rybrevant-Lazcluze treatment than after Tagrisso.

Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...

Elden grew up by Mount Kinabalu in Malaysia and hoped he'd one day climb it – and following his lung cancer diagnosis, he did. Discover how targeted therapy of a cancer-causing mutation have helped ...

Paid and presented by AstraZeneca. When Cleusa was diagnosed with advanced lung cancer, she needed support attending her appointments in the city. Find out how a respiratory programme is helping to ...

Despite meeting the primary endpoint in a Phase III study, two patients treated with Merck and Daiichi Sankyo’s experimental ...

Immunotherapy, which stimulates the body's immune system to fight tumours, has already been shown to be an effective weapon ...

The FDA previously rejected patritumab deruxtecan over manufacturing issues. Tuesday's study data should boost the companies' ...

A phase 3 trial of Daiichi Sankyo and Merck & Co.’s HER3-directed antibody-drug conjugate (ADC) has hit its primary endpoint, ...

In early April 2024, Goldman Sachs Inc.’s data revealed that short selling on individual US-listed stocks […] A Phase 3 trial ...